lung cancer

Research Reports
Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices
02/09/2024
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...
Poka Cui and colleagues...
02/09/2024
Journal of Clinical Pathways
News
Higher Out-of-Pocket Costs Associated With Decreased TKI Adherence in NSCLC
02/15/2021
02/15/2021
Journal of Clinical Pathways
News
Timely Specialty Palliative Care for NSCLC Associated With Cost-Savings
12/17/2020
12/17/2020
Journal of Clinical Pathways
Multiple Treatment Guideline Updates Released for Lung Cancer
Guideline Updates
Multiple Treatment Guideline Updates Released for Lung Cancer
05/19/2020
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...
The...
05/19/2020
Journal of Clinical Pathways
Managing Lung Nodules, Lung Cancer Screening During the Pandemic
Guideline Updates
Managing Lung Nodules, Lung Cancer Screening During the Pandemic
05/12/2020
A new expert panel consensus statement offers guidance for clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. The statement was published jointly in...
A new expert panel consensus statement offers guidance for clinicians managing lung cancer screening programs and patients with lung nodules during the COVID-19 pandemic. The statement was published jointly in...
A new...
05/12/2020
Journal of Clinical Pathways
Research Reports
Drug Costs vs Probability of Survival in Lung Cancer: Impact of Dosage, Duration, and Immune Checkpoint Inhibitor Combinations
06/18/2019
Abstract: Clinical guidelines and pathways recommend use of immune checkpoint inhibitors (ICI) in first- and second-line treatment of advanced/metastatic non-small cell lung cancer (amNSCLC). There is an unmet need...
Abstract: Clinical guidelines and pathways recommend use of immune checkpoint inhibitors (ICI) in first- and second-line treatment of advanced/metastatic non-small cell lung cancer (amNSCLC). There is an unmet need...
...
06/18/2019
Journal of Clinical Pathways
Research in Review
SBRT Deemed Safe and Effective in Older Patients With Lung Cancer
07/19/2017
JCP Editors
Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...
Stereotactic body radiation therapy (SBRT) is a safe treatment for patients aged 80 years or older with early-stage lung cancer, according to a recent study published in the International Journal of Radiation...
...
07/19/2017
Journal of Clinical Pathways
Research in Review
Model Predicts Tumor Spread in Lung Cancer
07/17/2017
JCP Editors
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
...
07/17/2017
Journal of Clinical Pathways
Research in Review
Lung Cancer Screening Is Cost-Effective, Identifies Other Conditions in High-Risk Patients
07/03/2017
JCP Editors
Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...
Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...
...
07/03/2017
Journal of Clinical Pathways
Research in Review
New Prognostic Model Accurately Predicts Survival in Lung Cancer With Brain Metastases
06/28/2017
JCP Editors
A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...
A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...
A new...
06/28/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use